Valuation: Evogene Ltd.

Market Cap 6.09M 0 5.42M 5.03M 4.56M 8.56M 577M 8.71M 60.33M 23.7M 302M 22.86M 22.39M 964M P/E 2026 *
-
P/E 2027 * -
Enterprise Value 6.09M 0 5.42M 5.03M 4.56M 8.56M 577M 8.71M 60.33M 23.7M 302M 22.86M 22.39M 964M EV / Sales 2026 *
4.24x
EV / Sales 2027 * 2.34x
Free-Float
75.61%
Yield 2026 *
-
Yield 2027 * -
1 day-1.84%
1 week-2.09%
Current month-8.35%
1 month-23.77%
3 months-31.94%
6 months-52.00%
Current year-60.94%
1 week 116.1
Extreme 116.1
127
1 month 113.3
Extreme 113.3
164.6
Current year 113.3
Extreme 113.3
410
1 year 113.3
Extreme 113.3
439.8
3 years 113.3
Extreme 113.3
3,700
5 years 113.3
Extreme 113.3
9,250
10 years 113.3
Extreme 113.3
33,500
Manager TitleAgeSince
Chief Executive Officer 60 01/12/2004
Corporate Officer/Principal - -
Corporate Officer/Principal - 01/01/2022
Director TitleAgeSince
Director/Board Member 60 -
Director/Board Member 77 03/06/2010
Chairman 60 01/06/2021
Date Insider Type Main position Quantity % Market Cap. Importance
04/09/26 Free

Chairman

10,000 0.0754%
04/09/26 Other

Director

2,500 0.0189%
04/09/26 Free

Director

2,500 0.0189%
Change 5-day change 1-year change 3-year change Capi.($)
-1.84%-2.09%-71.91%-94.12% 6.09M
+0.79%-6.46%+52.86%+71.34% 65.83B
+1.92%+8.89%+12.90%+82.75% 51.87B
+6.91%+6.41%+9.61%+73.07% 51.2B
+0.74%+2.75%+26.31%+45.29% 43.76B
+3.87%+10.15%+20.69%+132.73% 42.09B
+7.91%+4.30%+263.91%+602.72% 39.04B
-0.40%+9.42%+18.44%+59.06% 34B
+3.84%-4.94%+42.35%+8.92% 25.2B
+2.36%+4.62%+24.20%+31.02% 22.8B
Average +2.63%+0.44%+39.94%+101.28% 37.58B
Weighted average by Cap. +3.08%+0.62%+51.12%+124.45%

Financials

2026 *2027 *
Net sales 1.44M 0 1.28M 1.18M 1.07M 2.02M 136M 2.05M 14.21M 5.58M 71.19M 5.39M 5.27M 227M 2.6M 0 2.31M 2.14M 1.94M 3.65M 246M 3.71M 25.74M 10.11M 129M 9.75M 9.55M 411M
Net income -12.17M -0 -10.83M -10.04M -9.1M -17.1M -1.15B -17.38M -120M -47.32M -603M -45.65M -44.7M -1.92B -10.2M -0 -9.08M -8.41M -7.62M -14.33M -966M -14.57M -101M -39.66M -506M -38.26M -37.47M -1.61B
Net Debt - -
Projected Income Statement - Annual - Evogene Ltd.
Logo Evogene Ltd.
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Employees
52
Date Price Change Volume
20/10/26 ILA 117.40 -1.84% 66,273
19/10/26 ILA 119.60 +0.25% 102,759
16/10/26 ILA 119.30 -1.40% 78,333
15/10/26 ILA 121.00 -0.41% 19,717
14/10/26 ILA 121.50 -2.96% 39,709

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Evogene Ltd.
  1. Stock Market
  2. Stocks
  3. EVGN Stock